Laure Gossec, MD, PhD, discusses new research showing early responders maintain greater patient-reported outcome improvements through year 3.
Laure Gossec, MD, PhD
Advertisement
Professor of Rheumatology in Sorbonne Université and Pitié-Salpêtrière Hospital, Paris, France
Articles by Laure Gossec, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Rheumatology Live
1
Bimekizumab Beats Risankizumab on ACR50 in First IL-17A/F vs IL-23 Head-to-Head
2
Sonelokimab Reduces Inflammation, Osteoblastic Activity in Phase 2 Proof-of-Concept axSpA Study
3
OLINGUITO: Filgotinib Meets Phase 3 Primary Endpoint in r/nr-axSpA, With Xenofon Baraliakos, MD, PhD
4
Nipocalimab Demonstrates Proof of Concept for FcRn Blockade for SLE
5